Literature DB >> 15330167

Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.

Ulrich Brinck1, Susanne Jacobs, Michael Neuss, Kalman Tory, Werner Rath, Bettina Kulle, Laszlo Füzesi.   

Abstract

We investigated the correlations between growth patterns and E-cadherin expression by immunohistochemistry and the presence of mutations of exons 6-10 of the E-cadherin gene by PCR-SSCP, in 79 cases of invasive lobular and ductal breast cancer. E-cadherin expression showed a tendency to be lower in lobular than in ductal carcinomas (p=0.064). In 60% of lobular carcinomas the diffuse growth pattern and in 72% of ductal carcinomas the compact growth pattern predominated. E-cadherin expression was significantly lower in diffuse than in compact tumor area (p<0.001) and not related to carcinoma type when it was considered in tumor areas with either diffuse (p=0.278) or compact (p=0.128) growth pattern. No mutations were detected. In conclusion, loss of E-cadherin expression is related to an increase of diffuse growth pattern in both lobular and ductal types of breast cancer, and the differential proportions of growth patterns in both tumor types cause the tendency for lower E-cadherin expression in the lobular type.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330167

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway.

Authors:  Zimin Liu; Jian Zhang; Guangchen Hong; Jinping Quan; Lin Zhang; Meiqin Yu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

3.  Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer.

Authors:  Yu Yuecheng; Li Hongmei; Xin Xiaoyan
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

4.  Diffuse invasive breast carcinoma of no special type.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2015-10-31       Impact factor: 4.064

5.  Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

Authors:  Giovanni Ciriello; Michael L Gatza; Andrew H Beck; Matthew D Wilkerson; Suhn K Rhie; Alessandro Pastore; Hailei Zhang; Michael McLellan; Christina Yau; Cyriac Kandoth; Reanne Bowlby; Hui Shen; Sikander Hayat; Robert Fieldhouse; Susan C Lester; Gary M K Tse; Rachel E Factor; Laura C Collins; Kimberly H Allison; Yunn-Yi Chen; Kristin Jensen; Nicole B Johnson; Steffi Oesterreich; Gordon B Mills; Andrew D Cherniack; Gordon Robertson; Christopher Benz; Chris Sander; Peter W Laird; Katherine A Hoadley; Tari A King; Charles M Perou
Journal:  Cell       Date:  2015-10-08       Impact factor: 41.582

6.  Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.

Authors:  S R Boreddy; S K Srivastava
Journal:  Oncogene       Date:  2012-09-17       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.